Остеотери

Остеотери (Teriparatide) is a bone formation agent used to treat osteoporosis. This injectable medication helps increase bone density and reduce fracture risk. Suitable for postmenopausal women and men with high fracture risk. Prescription required in most regions.

Teriparatide is prescribed for osteoporosis management in adults at high risk of fracture. It stimulates new bone growth, improving bone mineral density over time. Often used when other treatments have not been effective or tolerated. May also be used for glucocorticoid-induced osteoporosis under medical supervision.

Users may notice gradual improvements in bone strength and reduced fracture risk with consistent use. Some report mild discomfort at the injection site. Effects vary by individual and depend on adherence to the prescribed regimen. Regular monitoring by a healthcare provider is recommended.

Store teriparatide in the refrigerator until use, avoiding freezing. Protect from light and keep the pen or vial capped when not in use. Discard after the expiration date or as directed. Do not use if the solution is cloudy or contains particles. Keep out of reach of children.

Teriparatide has limited known drug interactions but may be affected by other medications that alter calcium metabolism. Avoid combining with bisphosphonates, as they may reduce teriparatide’s bone-building effects. Consult a healthcare provider before starting or stopping any medications during treatment.